Your browser doesn't support javascript.
loading
Outcomes of patients with up to 6 years of follow-up from a phase 2 study of idelalisib for relapsed indolent lymphomas.
Wagner-Johnston, Nina D; Schuster, Stephen J; deVos, Sven; Salles, Gilles; Jurczak, Wojciech J; Flowers, Christopher R; Viardot, Andreas; Flinn, Ian W; Martin, Peter; Xing, Guan; Rajakumaraswamy, Nishanthan; Gopal, Ajay K.
Afiliación
  • Wagner-Johnston ND; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.
  • Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • deVos S; David Geffen School of Medicine at UCLA, Santa Monica, CA, USA.
  • Salles G; Hospices Civils de Lyon, University Claude Bernard, Lyon, France.
  • Jurczak WJ; Maria Sklodowska-Curie National Research Institute of Oncology, Kraków, Poland.
  • Flowers CR; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Viardot A; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Flinn IW; Hematologic Malignancies Research Program, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA.
  • Martin P; Division of Hematology/Oncology, Weill Cornell Medical College, New York, NY, USA.
  • Xing G; Gilead Sciences, Inc., Foster City, CA, USA.
  • Rajakumaraswamy N; Gilead Sciences, Inc., Foster City, CA, USA.
  • Gopal AK; University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Leuk Lymphoma ; 62(5): 1077-1087, 2021 05.
Article en En | MEDLINE | ID: mdl-33300385

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Quinazolinonas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Quinazolinonas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos